| Literature DB >> 35055316 |
Yu-Chieh Chang1,2, Te-Chun Hsieh2,3, Jui-Cheng Chen4,5,6, Kuan-Pin Wang7, Zong-Kai Hsu7, Pak-Ki Chan7, Chia-Hung Kao2,7,8,9.
Abstract
Parkinson's disease (PD), a progressive disease that affects movement, is related to dopaminergic neuron degeneration. Tc-99m Trodat-1 brain (TRODAT) single-photon emission computed tomography (SPECT) aids the functional imaging of dopamine transporters and is used for dopaminergic neuron enumeration. Herein, we employed a convolutional neural network to facilitate PD diagnosis through TRODAT SPECT, which is simpler than models such as VGG16 and ResNet50. We retrospectively collected the data of 3188 patients (age range 20-107 years) who underwent TRODAT SPECT between June 2011 and December 2019. We developed a set of functional imaging multiclassification deep learning algorithms suitable for TRODAT SPECT on the basis of the annotations of medical experts. We then applied our self-proposed model and compared its results with those of four other models, including deep and machine learning models. TRODAT SPECT included three images collected from each patient: one presenting the maximum absorption of the metabolic function of the striatum and two adjacent images. An expert physician determined that our model's accuracy, precision, recall, and F1-score were 0.98, 0.98, 0.98, and 0.98, respectively. Our TRODAT SPECT model provides an objective, more standardized classification correlating to the severity of PD-related diseases, thereby facilitating clinical diagnosis and preventing observer bias.Entities:
Keywords: Parkinson’s disease; Tc-99m Trodat-1 brain single-photon emission computed tomography; convolutional neural network; deep learning; dopamine transporter; machine learning; neural network
Year: 2021 PMID: 35055316 PMCID: PMC8780265 DOI: 10.3390/jpm12010001
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426
Figure 1Functional images marked for Parkinson’s disease severity by clinicians. From the top left to the bottom right: categories 0–5 (total: 6 categories). (A) category 0, normal striatal uptake bilaterally; (B) category 1, normal caudate uptake with putamen uptake loss of >50% on one side and <50% on the other; (C) category 2, normal caudate uptake with putamen uptake loss of >50% bilaterally or reduced caudate and putamen uptake of approximately 50% bilaterally; (D) category 3, caudate uptake loss of <50% with no putamen uptake; (E) category 4, a condition between categories 3 and 5; (F) category 5, no striatal uptake bilaterally.
Figure 2Flow of the application of our small convolutional neural network, which has a low number of parameters, to functional imaging.
Figure 3Architecture of SolaNet, our proposed model.
Quantity and proportion of imported model data.
| Dataset | Quantity | Proportion |
|---|---|---|
| Training data | 2390 | 75% |
| Validation data | 479 | 15% |
| Testing data | 319 | 10% |
Types and quantities of imported data.
| Severity (Physician Labeling) | Patients |
|---|---|
| 0 | 19 |
| 1 | 204 |
| 2 | 1010 |
| 3 | 1157 |
| 4 | 739 |
| 5 | 59 |
| Total | 3188 |
Figure 4Receiver operating characteristic curve of SolaNet.
Performance of SolaNet and other popular models.
| Model | Categories = 6 | |||||
|---|---|---|---|---|---|---|
| ACC | Precision | Recall | F1-Score | AUC | Params | |
| SolaNet | 0.62 | 0.61 | 0.62 | 0.6 | 0.92 | 1 |
| VGG16 | 0.56 | 0.54 | 0.56 | 0.54 | 0.89 | 25 |
| ResNet50 | 0.58 | 0.6 | 0.58 | 0.56 | 0.89 | 138 |
| Random Forest | 0.52 | 0.52 | 0.52 | 0.50 | 0.51 | -- |
| SVM | 0.44 | 0.45 | 0.44 | 0.44 | 0.48 | -- |
Performance summed up the +1 and −1 of SolaNet and other popular models.
| Model | Category = 6 Label + −1 | |||
|---|---|---|---|---|
| ACC | Precision | Recall | F1-Score | |
| SolaNet | 0.98 | 0.98 | 0.98 | 0.98 |
| VGG16 | 0.96 | 0.95 | 0.96 | 0.96 |
| ResNet50 | 0.96 | 0.95 | 0.96 | 0.95 |
| Random Forest | 0.97 | 0.96 | 0.97 | 0.96 |
| SVM | 0.93 | 0.93 | 0.93 | 0.93 |